RNS Number : 0550V
De La Rue PLC
28 November 2019
 

De La Rue plc

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The notification below is provided in accordance with the requirements of the EU Market Abuse Regulations.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ed Peppiatt and Sarah Peppiatt

2

 

Reason for the notification

 

a)

 

Position/status

 

Ed Peppiatt, General Counsel and Company Secretary (PDMR) and PCA to PDMR

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44 152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

Joint Purchase of 44,120 Ordinary Shares.

 

Following this transaction Mr Ed Peppiatt's beneficial holding is 51,527 ordinary shares.

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£1.390216455

44,120

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

 

 

 

44,120

 

£1.390216455

 

£61,336.35

e)

 

Date of the transaction

 

2019-11-27

f)

 

Place of the transaction

 

London Stock Exchange (XLON)

 

 

John Hermans, Deputy Company Secretary

Contact Number: 01256 605317

28 November 2019

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHEAKFPAFXNFFF